Brett Einerson
( out of 25 reviews )

Brett Einerson, MD, MPH, FACOG

Languages spoken: English

Clinical Locations

U of U Health Elko Specialty Clinic

Maternal Fetal Medicine Outreach Clinic
Elko
801-213-2995

University of Utah Hospital

University Maternal Fetal Medicine, Area E
Salt Lake City
801-213-2995

  • CLINICAL PRACTICE

    Dr. Einerson is a physician and Maternal-Fetal Medicine (MFM) expert at the University of Utah Health. He sees patients who have complex pregnancies or health conditions that can complicate pregnancy. His medical practice includes consultations with patients who already have an OBGYN or midwife, ultrasound consultations, prenatal care for complex pregnancies, deliveries of complex and routine pregnancies, and postpartum follow-up care. He sees patients for consultation and prenatal care in Salt Lake City at the University of Utah Medical Center and in Elko, Nevada at the University of Utah Specialty Clinic. He performs procedures and delivers pregnant patients at the University of Utah in Salt Lake City, Utah.

    Dr. Einerson takes care of patients with all types of high-risk pregnancy issues and specializes in placenta problems (including placenta accreta spectrum, placenta previa, and vasa previa), twin or triplet pregnancies, cervical insufficiency, and fetal genetic differences.

    Dr. Einerson performs a multitude of testing options and procedures in pregnancy including ultrasounds of the fetus and placenta starting in the first trimester, genetic screening, amniocentesis (collecting amniotic fluid) for genetic diagnosis, cerclage and other treatments to prevent preterm birth, vaginal birth, cesarean birth, vaginal delivery of complex situations (like twins and breech-presenting babies), external cephalic version (turning a breech or transverse baby to head-down) and treatments for placenta accreta spectrum including cesarean hysterectomy or conservative management.

    RESEARCH AND ACADEMIC BACKGROUND

    Dr. Einerson is an Assistant Professor of Obstetrics & Gynecology in the Division of Maternal-Fetal Medicine (MFM) at the University of Utah.

    Dr. Einerson’s research focuses on placenta accreta spectrum, severe maternal morbidity, quality improvement and patient safety, obstetric and postpartum hemorrhage, and cost-effectiveness. He has ongoing funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, K23HD106009) to study alternative treatments for placenta accreta spectrum (PAS). He was the recipient of a career develop award through the Maternal-Fetal Medicine Units (MFMU) Network to study the cost of care in patients undergoing induction of labor or expectant management at term in the ARRIVE trial. His research is supported by the University of Utah Vice President’s Clinical & Translational (VPCAT) Research Scholars Program and the Utah OBGYN Research Network (OGRN). His peer reviewed research has been published in Obstetrics & Gynecology, The American Journal of Obstetrics & Gynecology (AJOG), the British Journal of Obstetrics & Gynecology (BJOG), and BMJ Open. In 2020, he received the Roy M. Pitkin Award on behalf of the Department for an outstanding research publication in Obstetrics & Gynecology (PMID 32541288).

    Dr. Einerson is a nationally recognized clinical expert in diagnosis and management of placenta accreta spectrum disorders (PAS). He is Director of the Utah Placenta Accreta Program at the University of Utah. As one of the busiest referral programs for PAS in the United States, the program provides internationally recognized, cutting-edge, interdisciplinary approaches to diagnosis, treatment, patient-centered support for those affected by PAS. He is a Board Member of the Pan American Society for Placenta Accreta Spectrum (PAS2) and serves as that society’s Publications Committee Chair. In 2020 and 2021 he was co-director of the Society of Maternal Fetal Medicine (SMFM) Accreta Scientific Forum. In October 2022, he and the University of Utah hosted the 4th Annual National meeting of PAS2 in Salt Lake City, Utah. Given this expertise, he has been a speaker, lecturer, and podcast guest to discuss PAS for regional and national events including SMFM Post-Graduate Courses and Accreta Scientific Forum, the PAS2 National Conference, the Vanderbilt High Risk Pregnancy Seminar, the Park City Postgraduate OBGYN Course, the Healthful Woman Podcast, and CREOGs Over Coffee Podcast.

    Dr. Einerson is an engaged leader, award-winning educator, and effective mentor. He was a member of the SMFM Patient Safety and Quality Committee from 2016 to 2022, where he authored the SMFM Placenta Accreta Spectrum Safety Checklist. Locally, he is the Medical Director of Obstetric Emergency Services (OBES) at University of Utah Health Medical Center, Chair of the University of Utah Severe Maternal Morbidity Review Committee, and Member of the University Transfusion Committee. He is Associate Program Director (Research) for the University of Utah Maternal-Fetal Medicine (MFM) Fellowship. A devoted medical educator, he has received eight teaching awards from medical students and residents, including twice being named the recipient of the National Faculty Award from the American College of Obstetricians and Gynecologists (ACOG) and Council on Resident Education in Obstetrics & Gynecology (CREOG) for promoting high standards of residency education in the field of obstetrics and gynecology.

    Dr. Einerson received his medical degree from Wake Forest University School of Medicine in 2011. He completed a Masters in Public Health in Health Care Leadership in 2010 from the University of North Carolina in Chapel Hill. He completed a residency in Obstetrics & Gynecology at Northwestern University Feinberg School of Medicine in 2015. Thereafter, he has been at the University of Utah, first for Maternal-Fetal Medicine fellowship (completed in 2018) and now as faculty in the Department of Obstetrics & Gynecology. He is a Fellow of The American Congress of Obstetricians & Gynecologists (FACOG) and is board certified in both Obstetrics & Gynecology and Maternal-Fetal Medicine.

    Link to his research at: Google Scholar | Scopus | ORCID

    Specialties

    Board Certification

    American Board of Obstetrics & Gynecology
    American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)

    Patient Rating

    5.0 /5
    ( out of 25 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    June 15, 2024
    UH HOSPITALS AND CLINICS

    I honestly Love this man. He not only was very knowledgeable he was also, warm, kind and a great listener. I felt completely confident and comfortable in his care. He made an urgent and scary situation manageable. I owe him my life and my family and I are very grateful I'm still here.

    May 18, 2024
    UH HOSPITALS AND CLINICS

    Dr. Einerson and his MA's are so caring and attentive. Dr. Einerson is so knowledgeable and always puts my mind at ease when answering tough questions.

    March 14, 2024
    EXTERNAL SITE

    I felt the doctor was extremely positive and caring. I would recommend him 100%.

    March 09, 2024
    UH HOSPITALS AND CLINICS

    Dr. Einerson has made me feel confident and understood in my new pregnancy after losing twins in my first. He takes into account both my mental and physical health when we discuss our prenatal care plan. He takes the time to understand my fears and responds to them with facts, empathy, and a plan.

    January 04, 2024
    UH HOSPITALS AND CLINICS

    He was so informative, listened intently, and addressed every concern we had. I feel so lucky to have found him, and to be in his care!

    December 10, 2023
    UH HOSPITALS AND CLINICS

    Dr.Einerson is such an amazing Dr and surgeon. He saved mine and my baby's life. We're so grateful to have had him as our Doctor.

    December 01, 2023
    UH HOSPITALS AND CLINICS

    Dr. Einerson delivered difficult news with kindness and clarity. He listened to and addressed my questions and concerns.

    October 28, 2023
    UH HOSPITALS AND CLINICS

    Dr. Einerson makes me feel like I am his only patient. Even though he is extremely busy he takes the time to explain my complex diagnosis. He is also one of the few doctors who asks about and treats my mental health as well.

    October 17, 2023
    UH HOSPITALS AND CLINICS

    I am so impressed with Dr Einerson. I felt a lot of stress before this appointment and even though there's still a lot up in the air with my pregnancy and upcoming birth, I feel a huge sense of relief knowing that I am in good hands. I have full confidence in Dr. Einerson's competence and care.

    See More Patient Comments

  • CLINICAL PRACTICE

    Dr. Einerson is a physician and Maternal-Fetal Medicine (MFM) expert at the University of Utah Health. He sees patients who have complex pregnancies or health conditions that can complicate pregnancy. His medical practice includes consultations with patients who already have an OBGYN or midwife, ultrasound consultations, prenatal care for complex pregnancies, deliveries of complex and routine pregnancies, and postpartum follow-up care. He sees patients for consultation and prenatal care in Salt Lake City at the University of Utah Medical Center and in Elko, Nevada at the University of Utah Specialty Clinic. He performs procedures and delivers pregnant patients at the University of Utah in Salt Lake City, Utah.

    Dr. Einerson takes care of patients with all types of high-risk pregnancy issues and specializes in placenta problems (including placenta accreta spectrum, placenta previa, and vasa previa), twin or triplet pregnancies, cervical insufficiency, and fetal genetic differences.

    Dr. Einerson performs a multitude of testing options and procedures in pregnancy including ultrasounds of the fetus and placenta starting in the first trimester, genetic screening, amniocentesis (collecting amniotic fluid) for genetic diagnosis, cerclage and other treatments to prevent preterm birth, vaginal birth, cesarean birth, vaginal delivery of complex situations (like twins and breech-presenting babies), external cephalic version (turning a breech or transverse baby to head-down) and treatments for placenta accreta spectrum including cesarean hysterectomy or conservative management.

    RESEARCH AND ACADEMIC BACKGROUND

    Dr. Einerson is an Assistant Professor of Obstetrics & Gynecology in the Division of Maternal-Fetal Medicine (MFM) at the University of Utah.

    Dr. Einerson’s research focuses on placenta accreta spectrum, severe maternal morbidity, quality improvement and patient safety, obstetric and postpartum hemorrhage, and cost-effectiveness. He has ongoing funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, K23HD106009) to study alternative treatments for placenta accreta spectrum (PAS). He was the recipient of a career develop award through the Maternal-Fetal Medicine Units (MFMU) Network to study the cost of care in patients undergoing induction of labor or expectant management at term in the ARRIVE trial. His research is supported by the University of Utah Vice President’s Clinical & Translational (VPCAT) Research Scholars Program and the Utah OBGYN Research Network (OGRN). His peer reviewed research has been published in Obstetrics & Gynecology, The American Journal of Obstetrics & Gynecology (AJOG), the British Journal of Obstetrics & Gynecology (BJOG), and BMJ Open. In 2020, he received the Roy M. Pitkin Award on behalf of the Department for an outstanding research publication in Obstetrics & Gynecology (PMID 32541288).

    Dr. Einerson is a nationally recognized clinical expert in diagnosis and management of placenta accreta spectrum disorders (PAS). He is Director of the Utah Placenta Accreta Program at the University of Utah. As one of the busiest referral programs for PAS in the United States, the program provides internationally recognized, cutting-edge, interdisciplinary approaches to diagnosis, treatment, patient-centered support for those affected by PAS. He is a Board Member of the Pan American Society for Placenta Accreta Spectrum (PAS2) and serves as that society’s Publications Committee Chair. In 2020 and 2021 he was co-director of the Society of Maternal Fetal Medicine (SMFM) Accreta Scientific Forum. In October 2022, he and the University of Utah hosted the 4th Annual National meeting of PAS2 in Salt Lake City, Utah. Given this expertise, he has been a speaker, lecturer, and podcast guest to discuss PAS for regional and national events including SMFM Post-Graduate Courses and Accreta Scientific Forum, the PAS2 National Conference, the Vanderbilt High Risk Pregnancy Seminar, the Park City Postgraduate OBGYN Course, the Healthful Woman Podcast, and CREOGs Over Coffee Podcast.

    Dr. Einerson is an engaged leader, award-winning educator, and effective mentor. He was a member of the SMFM Patient Safety and Quality Committee from 2016 to 2022, where he authored the SMFM Placenta Accreta Spectrum Safety Checklist. Locally, he is the Medical Director of Obstetric Emergency Services (OBES) at University of Utah Health Medical Center, Chair of the University of Utah Severe Maternal Morbidity Review Committee, and Member of the University Transfusion Committee. He is Associate Program Director (Research) for the University of Utah Maternal-Fetal Medicine (MFM) Fellowship. A devoted medical educator, he has received eight teaching awards from medical students and residents, including twice being named the recipient of the National Faculty Award from the American College of Obstetricians and Gynecologists (ACOG) and Council on Resident Education in Obstetrics & Gynecology (CREOG) for promoting high standards of residency education in the field of obstetrics and gynecology.

    Dr. Einerson received his medical degree from Wake Forest University School of Medicine in 2011. He completed a Masters in Public Health in Health Care Leadership in 2010 from the University of North Carolina in Chapel Hill. He completed a residency in Obstetrics & Gynecology at Northwestern University Feinberg School of Medicine in 2015. Thereafter, he has been at the University of Utah, first for Maternal-Fetal Medicine fellowship (completed in 2018) and now as faculty in the Department of Obstetrics & Gynecology. He is a Fellow of The American Congress of Obstetricians & Gynecologists (FACOG) and is board certified in both Obstetrics & Gynecology and Maternal-Fetal Medicine.

    Link to his research at: Google Scholar | Scopus | ORCID

    Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Primary
    Academic Divisions Maternal Fetal Medicine
    Board Certification
    American Board of Obstetrics & Gynecology
    American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)

    Education history

    Fellowship Maternal-Fetal Medicine - University of Utah School of Medicine Fellow
    Obstetrics and Gynecology - Northwestern University Feinberg School of Medicine Chief Resident
    Residency Obstetrics and Gynecology - Northwestern University Feinberg School of Medicine Resident
    Health Care Leadership Program - University of North Carolina, Gillings School of Global Public Health M.P.H.
    Professional Medical Medicine - Wake Forest University School of Medicine M.D.
    Biology - Bethel University B.S.

    Selected Publications

    Journal Article

    1. Modest AM, Einerson BD, Nieto AJ, Shrivastava VK, Shamshirsaz AA, Shainker SA, Pan American Society for Placenta Accreta Spectrum (2024). Risk Profiling In Vitro Fertilization Pregnancies that Develop Placenta Accreta Spectrum. Am J Perinatol. (Read full article)
    2. Munoz JL, Einerson BD, Silver RM, Mulampurath S, Sherman LS, Rameshwar P, Prewit EB, Ramsey PS (2024). Serum exosomal microRNA pathway activation in placenta accreta spectrum: pathophysiology and detection. AJOG Glob Rep, 4(1), 100319. (Read full article)
    3. Bruno AM, Federspiel JJ, McGee P, Pacheco LD, Saade GR, Parry S, Longo M, Tita ATN, Gyamfi-Bannerman C, Chauhan SP, Einerson BD, Rood K, Rouse DJ, Bailit J, Grobman WA, Simhan HN, Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network (2024). Validation of Three Models for Prediction of Blood Transfusion during Cesarean Delivery Admission. Am J Perinatol. (Read full article)
    4. Arslan E, Einerson BD, Zhang J, Zhang J, Branch DW (2021). The Effect of "Off Hours" on Maternal and Perinatal Outcomes in a Diverse U.S. Cohort. Am J Perinatol, 41(1), 89-97. (Read full article)
    5. Society for Maternal-Fetal Medicine SMFM, Einerson BD, Healy AJ, Lee A, Warrick C, Combs CA, Hameed AB, SMFM Patient Safety and Quality Committee Electronic address smfmsmfmorg (2023). Society for Maternal-Fetal Medicine Special Statement: Emergency checklist, planning worksheet, and system preparedness bundle for placenta accreta spectrum. Am J Obstet Gynecol, 230(1), B2-B11. (Read full article)
    6. Jauniaux E, Fox KA, Einerson B, Hussein AM, Hecht JL, Silver RM (2023). Perinatal assessment of complex cesarean delivery: beyond placenta accreta spectrum. Am J Obstet Gynecol, 229(2), 129-139. (Read full article)
    7. Gatta LA, Ellestad SC, Boyd BK, Collins S, Einerson BD, Stephenson ML, Hammad I, Varvoutis MS, Honart AW, Federspiel JJ, Craig AM, Swartz A, Salinaro JR, Unnithan S, Weber J, Erkanli A, Gilner JB (2023). Validation of a sonographic checklist for the detection of histologic placenta accreta spectrum. Am J Obstet Gynecol MFM, 5(8), 101017. (Read full article)
    8. Monson MA, Chmait RH, Einerson B (2023). Fetoscopic Laser Ablation of Type II Vasa Previa: A Cost Benefit Analysis. Am J Perinatol. (Read full article)
    9. Einerson BD, Gilner JB, Zuckerwise LC (2023). Placenta Accreta Spectrum. Obstet Gynecol, 142(1), 31-50. (Read full article)
    10. Khoury-Collado F, Newton JM, Brook OR, Carusi DA, Shrivastava VK, Crosland BA, Fox KA, Khandelwal M, Karam AK, Bennett KA, Sandlin AT, Shainker SA, Einerson BD, Belfort MA, Pan-American Society for Placenta Accreta Spectrum (2023). Surgical Techniques for the Management of Placenta Accreta Spectrum. Am J Perinatol, 40(9), 970-979. (Read full article)
    11. Einerson BD, Shamshirsaz AA, Stephenson ML, Khandelwal M, Holt R, Duzyj CM, Shrivastava VK (2023). The Need for Presurgical Evaluation for Placenta Accreta Spectrum. Am J Perinatol, 40(9), 996-1001. (Read full article)
    12. Khandelwal M, Shipp TD, Zelop CM, Abuhamad AZ, Afshar Y, Einerson BD, Fox KA, Huisman TAGM, Lyell DJ, Perni U, Platt LD, Shainker SA, Pan American Society for Placenta Accreta Spectrum PAS2 (2023). Imaging the Uterus in Placenta Accreta Spectrum Disorder. Am J Perinatol, 40(9), 1013-1025. (Read full article)
    13. Jauniaux E, DAntonio F, Bhide A, Prefumo F, Silver RM, Hussein AM, Shainker SA, Chantraine F, Alfirevic Z, Delphi consensus expert panel (2022). Modified Delphi study of ultrasound signs associated with placenta accreta spectrum. Ultrasound Obstet Gynecol, 61(4), 518-525. (Read full article)
    14. Einerson BD, Kennedy A, Silver RM, Branch DW, Comstock J, Woodward PJ (2023). Ultrasonography of the Explanted Uterus in Placenta Accreta Spectrum: Correlation With Intraoperative Findings and Gross Pathology. Obstet Gynecol, 141(3), 544-554. (Read full article)
    15. Detlefs SE, Carusi DA, Modest AM, Einerson BD, Lyell D, Grace MR, Shrivastava VK, Khandelwal M, Salmanian B, Shainker SA, Fox KA, Subramaniam A, Crosland A, Duryea EL, Shamshirsaz AA, Shrestha K, Belfort MA, Silver RM, Clark SL, Shamshirsaz AA (2022). The Association between Placenta Accreta Spectrum Severity and Incidence of Small for Gestational Age Neonates. Am J Perinatol, 40(1), 9-14. (Read full article)
    16. Einerson BD, Nelson R, Botto LD, Minich LL, Krikov S, Waitzman N, Pinto NM (2022). Prenatally diagnosed congenital heart disease: the cost of maternal care. J Matern Fetal Neonatal Med, 35(26), 10428-10434. (Read full article)
    17. Salmanian B, Einerson BD, Carusi DA, Shainker SA, Nieto-Calvache AJ, Shrivastava VK, Subramaniam A, Zuckerwise LC, Lyell DJ, Khandelwal M, Fitzgerald GD, Hessami K, Fox KA, Silver RM, Shamshirsaz AA (2022). Timing of delivery for placenta accreta spectrum: the Pan-American Society for the Placenta Accreta Spectrum experience. Am J Obstet Gynecol MFM, 4(6), 100718. (Read full article)
    18. Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, Branch DW, Maurer KA, Dood RL, Debbink MP, Silver RM, Einerson BD (2022). Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstet Gynecol, 140(5), 806-811. (Read full article)
    19. Hessami K, Salmanian B, Einerson BD, Carusi DA, Shamshirsaz AA, Shainker SA, Subramaniam A, Shrivastava VK, Nieto-Calvache AJ, Gilner JB, Khandelwal M, Backer-Meurke S, Cimic A, Aalipour S, Grace MR, Fox KA, Lyell DJ, Belfort MA, Silver RM, Shamshirsaz AA (2022). Clinical Correlates of Placenta Accreta Spectrum Disorder Depending on the Presence or Absence of Placenta Previa: A Systematic Review and Meta-analysis. Obstet Gynecol, 140(4), 599-606. (Read full article)
    20. Bridges AG, Allshouse AA, Canfield DR, Grover BW, Son SL, Einerson BD, Silver RM, Haas DM, Grobman WA, Simhan HN, Day RC, Blue NR (2022). Association of Prostaglandin Use for Cervical Ripening with Mode of Delivery in Small for Gestational Age versus Non-Small for Gestational Age Neonates. Am J Perinatol. (Read full article)
    21. Richards DS, Benson AE, Einerson BD (2022). Confirmatory Middle Cerebral Artery Doppler Testing in Alloimmunized Patients with Suspected Fetal Anemia. Am J Perinatol. (Read full article)
    22. Debbink MP, Metz TD, Nelson RE, Janes SE, Kroes A, Begaye LJ, Heuser CC, Smid MC, Silver RM, Varner MW, Einerson BD (2021). Directly Measured Costs of Severe Maternal Morbidity Events during Delivery Admission Compared with Uncomplicated Deliveries. Am J Perinatol, 39(6), 567-576. (Read full article)
    23. Jauniaux E, Hussein AM, Einerson BD, Silver RM (2022). Debunking 20(th) century myths and legends about the diagnosis of placenta accreta spectrum. Ultrasound Obstet Gynecol, 59(4), 417-423. (Read full article)
    24. Givens M, Einerson BD, Allshouse AA, Bruno AM, Hammad I, Debbink MP, Branch DW, Silver RM (2021). Trends in Unplanned Peripartum Hysterectomy in the United States, 2009-2020. Obstet Gynecol, 139(3), 449-451. (Read full article)
    25. McLaughlin HD, Benson AE, Scaglione MA, Saviers-Steiger JS, Canfield DR, Debbink MP, Silver RM, Einerson BD (2022). Association between short interpregnancy interval and placenta accreta spectrum. AJOG Glob Rep, 2(2), 100051. (Read full article)
    26. Saunders SJ, Grisamore JL, Wong T, Torrejon Torres R, Saunders R, Einerson B (2022). Moving preinduction cervical ripening to a lower acuity inpatient setting using the synthetic hygroscopic cervical dilator: a cost-consequence analysis for the United States. J Med Econ, 25(1), 1185-1198. (Read full article)
    27. Einerson BD, Watt MH, Sartori B, Silver R, Rothwell E (2021). Lived experiences of patients with placenta accreta spectrum in Utah: a qualitative study of semi-structured interviews. BMJ Open, 11(11), e052766. (Read full article)
    28. Combs CA, Einerson BD, Toner LE, Patient Safety and Quality Committee Society for Maternal-Fetal Medicine Electronic address smfmsmfmorg (2021). Society for Maternal-Fetal Medicine Special Statement: Surgical safety checklists for cesarean delivery. Am J Obstet Gynecol, 225(5), B43-B49. (Read full article)
    29. Bruno AM, Olmsted MW, Martin V, Einerson BD, Metz TD, Allshouse AA, Scott JR, Blue NR (2021). Rigor, reproducibility, and transparency of randomized controlled trials in obstetrics and gynecology. Am J Obstet Gynecol MFM, 3(6), 100450. (Read full article)
    30. Benson AE, Metcalf RA, Cail K, Rollins MD, Warrick CM, Falkner D, Clark EAS, Nelson RE, Einerson BD (2021). Transfusion Preparedness in the Labor and Delivery Unit: An Initiative to Improve Safety and Cost. Obstet Gynecol, 138(5), 788-794. (Read full article)
    31. Bruno AM, Shea AE, Einerson BD, Metz TD, Allshouse AA, Scott JR, Blue NR (2021). Impact of the p-Value Threshold on Interpretation of Trial Outcomes in Obstetrics and Gynecology. Am J Perinatol, 38(12), 1223-1230. (Read full article)
    32. Einerson BD, Silver RM, Jauniaux E (2021). Placenta accreta spectrum: welcome progress and a call for standardisation. BJOG, 128(10), 1656-1657. (Read full article)
    33. Afshar Y, Dong J, Zhao P, Li L, Wang S, Zhang RY, Zhang C, Yin O, Han CS, Einerson BD, Gonzalez TL, Zhang H, Zhou A, Yang Z, Chou SJ, Sun N, Cheng J, Zhu H, Wang J, Zhang TX, Lee YT, Wang JJ, Teng PC, Yang P, Qi D, Zhao M, Sim MS, Zhe R, Goldstein JD, Williams J 3rd, Wang X, Zhang Q, Platt LD, Zou C, Pisarska MD, Tseng HR, Zhu Y (2021). Circulating trophoblast cell clusters for early detection of placenta accreta spectrum disorders. Nat Commun, 12(1), 4408. (Read full article)
    34. Lee W, Fox KA, Cassady CI, Collins S, Einerson BD, Hobson SR, Palacios-Jaraquemada JM, Shrivastava VK (2021). Placenta Accreta Spectrum 2021: Roundtable Discussion. J Ultrasound Med. (Read full article)
    35. Einerson BD, Weiniger CF (2021). Placenta accreta spectrum disorder: updates on anesthetic and surgical management strategies. Int J Obstet Anesth, 46, 102975. (Read full article)
    36. Swanson K, Debbink M, Letourneau JM, Kuppermann M, Einerson BD (2021). Association of multifetal gestation with obstetric and neonatal outcomes in gestational carrier pregnancies. J Assist Reprod Genet, 38(3), 661-667. (Read full article)
    37. Ibrahim Y, Einerson B, Carrell DT, Emery BR, Johnstone E (2020). The hamster egg penetration test may decrease intracytoplasmic sperm injection utilization while maintaining high conventional fertilization rates. Asian J Androl, 23(1), 11-15. (Read full article)
    38. Swanson K, Letourneau JM, Kuppermann M, Einerson BD (2020). Obstetric morbidity in gestational carrier pregnancies: a population-based study. J Assist Reprod Genet, 38(1), 177-183. (Read full article)
    39. Kuramoto G, Hammad IA, Einerson BD, Allshouse AA, Debbink M, Grainger DW, Silver RM, Okano T (2020). Human Mesenchymal Stem Cell Sheets Improve Uterine Incision Repair in a Rodent Hysterotomy Model. Am J Perinatol, 39(11), 1212-1222. (Read full article)
    40. Shainker SA, Silver RM, Modest AM, Hacker MR, Hecht JL, Salahuddin S, Dillon ST, Ciampa EJ, DAlton ME, Otu HH, Abuhamad AZ, Einerson BD, Branch DW, Wylie BJ, Libermann TA, Karumanchi SA (2020). Placenta accreta spectrum: biomarker discovery using plasma proteomics. Am J Obstet Gynecol, 223(3), 433.e1-433.e14. (Read full article)
    41. Swanson K, Letourneau JM, Kuppermann M, Einerson BD (2020). Reproductive Travel of Intended Parents for Delivery of Gestational Carrier Pregnancies. Obstet Gynecol, 136(3), 591-596. (Read full article)
    42. Carusi DA, Fox KA, Lyell DJ, Perlman NC, Aalipour S, Einerson BD, Belfort MA, Silver RM, Shamshirsaz AA (2020). Placenta Accreta Spectrum Without Placenta Previa. Obstet Gynecol, 136(3), 458-465. (Read full article)
    43. Grover B, Einerson BD, Keenan KD, Gibbins KJ, Callaway E, Lopez S, Silver RM (2020). Patient-Reported Health Outcomes and Quality of Life after Peripartum Hysterectomy for Placenta Accreta Spectrum. Am J Perinatol. (Read full article)
    44. Monson M, Heuser C, Einerson BD, Esplin I, Snow G, Varner M, Esplin MS (2020). Evaluation of an external fetal electrocardiogram monitoring system: a randomized controlled trial. Am J Obstet Gynecol, 223(2), 244.e1-244.e12. (Read full article)
    45. Swanson K, Letourneau JM, Kuppermann M, Einerson BD (2020). Association of Obstetric and Neonatal Outcomes With Deviation From Guidelines for Gestational Carriers. Obstet Gynecol, 136(2), 387-393. (Read full article)
    46. Einerson BD, Nelson RE, Sandoval G, Esplin MS, Branch DW, Metz TD, Silver RM, Grobman WA, Reddy UM, Varner M, Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2021). Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women. Obstet Gynecol, 136(1), 19-25. (Read full article)
    47. Einerson BD (2020). Should patients in the third trimester with a history of bariatric surgery receive growth ultrasound? BJOG, 127(7), 847. (Read full article)
    48. Einerson BD, Comstock J, Silver RM, Branch DW, Woodward PJ, Kennedy A (2020). Placenta Accreta Spectrum Disorder: Uterine Dehiscence, Not Placental Invasion. Obstet Gynecol, 135(5), 1104-1111. (Read full article)
    49. Einerson B (2020). Are there any good data to support outpatient cervical ripening? BJOG, 127(5), 580. (Read full article)
    50. Einerson BD, Grobman WA (2019). Elective induction of labor: friend or foe? Semin Perinatol, 44(2), 151214. (Read full article)
    51. Son SL, Benson AE, Hart Hayes E, Subramaniam A, Clark EAS, Einerson BD (2019). Outpatient Cervical Ripening: A Cost-Minimization and Threshold Analysis. Am J Perinatol, 37(3), 245-251. (Read full article)
    52. Einerson BD, Rodriguez CE, Silver RM, Donnelly MA, Kennedy AM, Woodward PJ (2020). Accuracy and Interobserver Reliability of Magnetic Resonance Imaging for Placenta Accreta Spectrum Disorders. Am J Perinatol, 38(9), 960-967. (Read full article)
    53. Wu J, Einerson B, Shaw JM, Nygaard IE, Sheng X, Wolpern A, Egger MJ (2019). Association between sleep quality and physical activity in postpartum women. Sleep Health, 5(6), 598-605. (Read full article)
    54. Sudhof LS, Shainker SA, Einerson BD (2019). Tranexamic acid in the routine treatment of postpartum hemorrhage in the United States: a cost-effectiveness analysis. Am J Obstet Gynecol, 221(3), 275.e1-275.e12. (Read full article)
    55. Einerson BD (2019). QALYs in obstetrics: not the whole story. BJOG, 126(10), 1251. (Read full article)
    56. Smid MC, Stone NM, Baksh L, Debbink MP, Einerson BD, Varner MW, Gordon AJ, Clark EAS (2019). Pregnancy-Associated Death in Utah: Contribution of Drug-Induced Deaths. Obstet Gynecol, 133(6), 1131-1140. (Read full article)
    57. Einerson BD, Rodriguez CE, Kennedy AM, Woodward PJ, Donnelly MA, Silver RM (2018). Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders. Am J Obstet Gynecol, 218(6), 618.e1-618.e7. (Read full article)
    58. Gibbins KJ, Einerson BD, Varner MW, Silver RM (2018). Placenta previa and maternal hemorrhagic morbidity. J Matern Fetal Neonatal Med, 31(4), 494-499. (Read full article)
    59. Einerson BD, Stehlikova Z, Nelson RE, Bellows BK, Kawamoto K, Clark EAS (2017). Transfusion Preparedness Strategies for Obstetric Hemorrhage: A Cost-Effectiveness Analysis. Obstet Gynecol, 130(6), 1347-1355. (Read full article)
    60. Einerson BD, Son M, Schneider P, Fields I, Miller ES (2016). The association between intrauterine balloon tamponade duration and postpartum hemorrhage outcomes. Am J Obstet Gynecol, 216(3), 300.e1-300.e5. (Read full article)
    61. Son M, Einerson BD, Schneider P, Fields IC, Grobman WA, Miller ES (2017). Is There an Association Between Indication for Intrauterine Balloon Tamponade and Balloon Failure? Am J Perinatol, 34(2), 164-168. (Read full article)
    62. Einerson BD, Grobman WA, Miller ES (2016). Cost-effectiveness of risk-based screening for cervical length to prevent preterm birth. Am J Obstet Gynecol, 215(1), 100.e1-7. (Read full article)
    63. Bortoletto P, Einerson BD, Miller ES, Milad MP (2015). A Cost-Effectiveness Analysis of Morcellation Hysterectomy for Fibroids. J Minim Invasive Gynecol, 22(6S), S58. (Read full article)
    64. Bortoletto P, Einerson BD, Miller ES, Milad MP (2015). Cost-Effectiveness Analysis of Morcellation Hysterectomy for Myomas. J Minim Invasive Gynecol, 22(5), 820-6. (Read full article)
    65. Einerson BD, Miller ES, Grobman WA (2015). Does a postpartum hemorrhage patient safety program result in sustained changes in management and outcomes? Am J Obstet Gynecol, 212(2), 140-4.e1. (Read full article)
    66. Miller ES, Einerson B, Sahabi S, Grobman WA (2014). Association between second-trimester cervical length and cesarean delivery in multiparas. J Ultrasound Med, 33(10), 1733-6. (Read full article)
    67. Einerson BD, Huffman JK, Istwan NB, Rhea DJ, Joy SD (2011). New gestational weight gain guidelines: an observational study of pregnancy outcomes in obese women. Obesity (Silver Spring), 19(12), 2361-4. (Read full article)

    Review

    1. Javinani A, Qaderi S, Hessami K, Shainker SA, Shamshirsaz AA, Fox KA, Mustafa HJ, Subramaniam A, Khandelwal M, Sandlin AT, Duzyj CM, Lyell DJ, Zuckerwise LC, Newton JM, Kingdom JC, Harrison RK, Shrivastava VK, Greiner AL, Loftin R, Genc MR, Atasi LK, Abdel-Razeq SS, Bennett KA, Carusi DA, Einerson BD, Gilner JB, Carver AR, Silver RM, Shamshirsaz AA (2023). Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and meta-analysis. [Review]. Am J Obstet Gynecol, 230(5), 485-492.e7. (Read full article)
    2. Fitzgerald GD, Newton JM, Atasi L, Buniak CM, Burgos-Luna JM, Burnett BA, Carver AR, Cheng C, Conyers S, Davitt C, Deshmukh U, Donovan BM, Easter SR, Einerson BD, Fox KA, Habib AS, Harrison R, Hecht JL, Licon E, Nino JM, Munoz JL, Nieto-Calvache AJ, Polic A, Ramsey PS, Salmanian B, Shamshirsaz AA, Shamshirsaz AA, Shrivastava VK, Woolworth MB, Yurashevich M, Zuckerwise L, Shainker SA, Pan-American Society for Placenta Accreta Spectrum (2023). Placenta accreta spectrum care infrastructure: an evidence-based review of needed resources supporting placenta accreta spectrum care. [Review]. Am J Obstet Gynecol MFM, 6(1), 101229. (Read full article)
    3. Einerson BD, Sandlin AT, Afshar Y, Sharawi N, Fox KA, Newton JM, Shainker SA, Pezeshkmehr A, Carusi DA, Moroz L (2023). General Management Considerations for Placenta Accreta Spectrum. [Review]. Am J Perinatol, 40(9), 1026-1032. (Read full article)

    Editorial

    1. Einerson BD (2023). Conservative management for placenta accreta spectrum: questions and barriers remain but are surmountable. Am J Obstet Gynecol MFM, 5(3), 100859. (Read full article)

    Letter

    1. Einerson BD, Allshouse AA, Sandoval G, Nelson RE, Esplin MS, Varner M, Grobman WA, Metz TD, Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD Maternal-Fetal Medicine Units Network (2024). Source of variation in cost of obstetrical care for low-risk nulliparas at term. [Letter to the editor]. Am J Obstet Gynecol, 230(5), e99-e100. (Read full article)
    2. Bruno AM, Allshouse AA, Einerson BD, Campbell HM, Branch DW, Silver RM, Metz TD (2022). Trends in postpartum venous thromboembolism and chemical prophylaxis among insured US patients. [Letter to the editor]. Am J Obstet Gynecol MFM, 4(4), 100620. (Read full article)
    3. Shamshirsaz AA, Carusi D, Shainker SA, Einerson B, Khandelwal M, Erfani H, Shamshirsaz AA, Modest AM, Aalipour S, Fox KA, Lyell DJ, Belfort MA, Silver RM (2020). Characteristics and outcomes of placenta accreta spectrum in twins versus singletons: a study from the Pan American Society for Placenta Accreta Spectrum (PAS2). [Letter to the editor]. Am J Obstet Gynecol, 222(6), 624-625. (Read full article)
    4. Einerson BD (2018). How would you help a colleague dealing with the stress of an adverse outcome? A report from #BlueJC. [Letter to the editor]. BJOG, 125(8), 1044. (Read full article)
    5. Einerson BD (2017). A report from #BlueJC: Would you recommend cranberry capsules to prevent postoperative bacteriuria? [Letter to the editor]. BJOG, 125(1), 98. (Read full article)

    Video/Film/CD/Web/Podcast

    1. Falkner J, Einerson B (2017). Nights and Weekends on the Maternity Ward [Podcast]. Common Sense Pregnancy. Available: https://commonsensepregnancyparentingandpower.libsyn.com/68-nights-and-weekends-on-the-maternity-ward.

  • News & Podcasts

    News